Close

Sign in
Sign up

Menu

Intel
Data search
Signals
Startup Concierge
Get intel

Home
News
Egle Therapeutics raised €40M from LSP and Bpifrance.

Egle Therapeutics raised €40M from LSP and Bpifrance.

Biotech Health services

France

Belgium

Netherlands

Japan

Investments

14 October 2021

Share:

Egle Therapeutics (company)

France

Biotech Health services

Total investments received (USD): 46.22m

Round value (USD): 46.22m

Round investors: Bpifrance Fundplus LSP (Life Sciences Partners) Takeda Pharmaceutical Company Limited Bioqube Ventures

Company: Egle Therapeutics

Industry: Biotech Health services

Related deals

SeqOne Genomics in a €20M series A equity deal ked by Omnes, Merieux Equity Partners, joined by Software Club, Irdi and Elaia.

Biotech Competitive Intelligence Health services Software Services

France

Investments 20 January 2022

Coave Therapeutics raised €33.1 million in an extended series B led by Seroba Life Sciences

Biotech Health services

France

Belgium

Ireland

Investments 22 July 2021

Xenothera in a €20 million funding round led by the European fund EIC Fund and the Nabuboto holding company.

Biotech Health services Manufacturing

France

Belgium

Investments 28 June 2021

Sidebar

Verticals

Financial Services
Food Industry
Education
E-commerce
Health services
Marketplace

Benelux

Belgium
Netherlands

DACH

Austria
Germany
Switzerland

Nordics and Baltics

Denmark
Estonia
Finland
Iceland
Latvia
Lithuania
Norway
Sweden

Western Europe

France
Ireland
Italy
Portugal
Spain
United Kingdom

About
Contact
Terms of service
Privacy policy

© All rights reserved Nordic 9 2016-2026. Made with in Stockholm

Top